SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, Zhuoming Liu, Baoling Ying, Wooseob Kim, Aaron J. Schmitz, Tingting Lei, Stephen Horváth, Alexandria J. Sturtz, Katherine M. McIntire, Birk Evavold, Fangjie Han, Suzanne M. Scheaffer, Isabella Fox, Senaa F. Mirza, Luis Parra-Rodriguez, Raffael Nachbagauer, Biliana Nestorova, Spyros Chalkias, Christopher W Farnsworth, Michael K. Klebert, Iskra Pusic, Benjamin S. Strnad, William D. Middleton, Sharlene A. Teefey, Sean P. J. Whelan, Michael Diamond, Robert Paris, Jane A. O’Halloran, Rachel M. Presti, Jackson S. Turner, Ali H. Ellebedy
Topics & Concepts
Monoclonal antibodyEpitopeGerminal centerBivalent (engine)VirologyMessenger RNABiologyAntibodyAntigenMemory B cellB cellImmunologyGeneticsChemistryGeneMetalOrganic chemistrySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesViral gastroenteritis research and epidemiology